Audentes Therapeutics
Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.. Learn more
Launch date
Employees
Market cap
AUD123m
Enterprise valuation
(AUD152m) (Public information from Sep 2024)
Share price
$4.27 BOLD
San Francisco California (HQ)
Authorizing premium user...